Howard V. Raff Ph.D.
Dr. Howard V. Raff is the Chief Operating Officer at APT Pharmaceuticals, a drug development company focused on repurposing well-characterized drugs for under-served populations. Howie previously served as the Head of West Coast Operations for The Biologics Consulting Group and held executive positions for Chiron Corporation. He also spent 11 years in discovery research and development for Bristol-Myers Squibb. Howie has been involved with the development and approval of several drugs in the U.S. and Europe, including: CTLA4-lg, Proleukin, Menjugate vaccine and Cubicin. He earned a Ph.D in immunology from Washington State University and earned a fellowship from the Howard Hughes Medical Institute at the University of California – San Francisco.